Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Control Governance: Regulatory Bodies and Their Impact01:03

Drug Control Governance: Regulatory Bodies and Their Impact

Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with a...
Drug Regulation01:25

Drug Regulation

Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Drug Classes and Categories01:25

Drug Classes and Categories

Drugs can be classified according to their chemical composition or their intended therapeutic application. For instance, anti-infective agents that possess the ability to eliminate pathogens or suppress their growth and reproduction can be grouped based on the organisms they target or their chemical structure. Furthermore, drugs can be divided into prescription, nonprescription, or controlled substances. Prescription medications, such as antibiotics, require oversight from a licensed healthcare...
Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Drug Concentrations: Measurements01:23

Drug Concentrations: Measurements

Drug concentration is the quantity of a drug present in a biological sample. Measuring drug amounts in biological samples allows the clinician to understand how a drug is absorbed, distributed, metabolized, and excreted. Samples can be obtained through invasive or non-invasive methods. Invasive techniques involve surgical or parenteral interventions to gather blood, cerebrospinal fluid, or tissue biopsy. Conversely, non-invasive approaches provide samples like urine, feces, and saliva.
Plasma —...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lessons from COVID-19: Perspectives of senior managers and decision-makers in substance use services in Wales.

Substance abuse treatment, prevention, and policy·2026
Same author

Retraction notice to "The impact of medically supervised injection centres on drug-related harms: A meta-analysis" [International Journal of Drug Policy Volume 59 (2018) 98-107].

The International journal on drug policy·2025
Same author

Assessing the early influence of COVID-19 in an analysis of the immediate implementation of Minimum Pricing for Alcohol on drinkers in Wales.

Nordisk alkohol- & narkotikatidskrift : NAT·2024
Same author

Lessons from the COVID-19 pandemic for substance misuse services: findings from a peer-led study.

Harm reduction journal·2022
Same author

Adapting existing behaviour: Perceptions of substance switching and implementation of minimum pricing for alcohol in Wales.

Nordisk alkohol- & narkotikatidskrift : NAT·2022
Same author

Addressing fentanyl-related harms: maximizing the efficiency of innovative interventions.

Addiction (Abingdon, England)·2020

Related Experiment Video

Updated: Jun 14, 2026

Color Spot Test As a Presumptive Tool for the Rapid Detection of Synthetic Cathinones
06:06

Color Spot Test As a Presumptive Tool for the Rapid Detection of Synthetic Cathinones

Published on: February 5, 2018

Is UK drug policy evidence based?

Trevor Bennett1, Katy Holloway

  • 1University of Glamorgan, Centre for Criminology, Pontypridd, CF37 1DL, United Kingdom. thbennet@glam.ac.uk

The International Journal on Drug Policy
|March 30, 2010
PubMed
Summary

UK drug strategy policies are often not truly evidence-based. While research quality is generally good, its interpretation and reporting can be biased, undermining effective drug misuse policy.

Area of Science:

  • Public Health Policy
  • Substance Misuse Research

Background:

  • UK public services are mandated to create evidence-based policies, especially for drug misuse.
  • Concerns exist regarding the practical implementation of evidence-based policymaking in the UK.
  • This study assesses the evidence-based nature of the UK's drug strategy.

Purpose of the Study:

  • To evaluate the extent to which the UK drug strategy aligns with evidence-based principles.
  • To analyze the quality and application of evidence used in UK drug policy.

Main Methods:

  • Case studies of policies within the four main strands of the UK drug strategy were examined.
  • Evidence cited by the government for policy justification was scrutinized.
  • Published sources of evidence were compared against government reporting.

More Related Videos

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
10:17

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

Related Experiment Videos

Last Updated: Jun 14, 2026

Color Spot Test As a Presumptive Tool for the Rapid Detection of Synthetic Cathinones
06:06

Color Spot Test As a Presumptive Tool for the Rapid Detection of Synthetic Cathinones

Published on: February 5, 2018

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
10:17

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

Main Results:

  • The quality of the underlying research was generally adequate.
  • Significant issues were identified in the interpretation and reporting of research findings.
  • Two case studies showed bias in research selection, and two exhibited unrepresentative reporting of conclusions.

Conclusions:

  • Evidence is not the sole or primary driver in the formulation of UK drug policy.
  • Multiple factors influence policy generation, making an exclusive focus on evidence unrealistic.